In this study, actinomycin D (15) was found to significantly downregulate the expression levels of several glioma metabolic enzymes, including HK2 and PKM2 from glycolysis, GLS from glutaminolysis and FASN from lipogenesis [37]. Here, GLS is linked to central nervous system cancer.